Response to: ‘The utility of the HEp-2000 antinuclear antibody substrate’ by Lee et al | Annals of the Rheumatic Diseases

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Archive
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

You are viewing from: Department GEZ-LTA Erasmushogeschool

Article info

Correspondence response

Response to: ‘The utility of the HEp-2000 antinuclear antibody substrate’ by Lee et al

Free

Authors

Jan Damoiseaux Maastricht University Medical Center, Maastricht, The Netherlands PubMed articles Google scholar articles
Edward K Chan Department of Oral Biology, University of Florida, Gainesville, Florida, United States PubMed articles Google scholar articles

Correspondence to Dr Jan Damoiseaux, Maastricht University Medical Center, Maastricht 6229 HX, The Netherlands; jan.damoiseaux{at}mumc.nl

Citation

Damoiseaux J, Chan EK

Response to: ‘The utility of the HEp-2000 antinuclear antibody substrate’ by Lee et al

Annals of the Rheumatic Diseases 2020;79:e68.

Publication history

Received April 30, 2019
Accepted April 30, 2019
First published May 14, 2019.

Online issue publication

May 20, 2020

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.